Clinical outcomes of online adaptive RT and conventional RT for muscle invasive bladder cancer.

被引：0
|
作者：
Yeh, J. [1 ]
Foroudi, F. [2 ]
Tai, K. H. [1 ]
Bressel, M. [1 ]
Kron, T. [1 ]
机构：
[1] Peter MacCallum Canc Ctr, Radiat Oncol, Melbourne, Vic, Australia
[2] Austin Hlth, Olivia Newton John Canc Wellness & Res Ctr, Radiat Oncol, Melbourne, Vic, Australia
来源：
RADIOTHERAPY AND ONCOLOGY | 2021年 / 161卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD-0851
引用
收藏
页码：S685 / S685
页数：1
相关论文
共 50 条
  • [41] Treatment Options and Outcomes in Nonmetastatic Muscle Invasive Bladder Cancer
    Ghandour, Rashed
    Singla, Nirmish
    Lotan, Yair
    TRENDS IN CANCER, 2019, 5 (07): : 426 - 439
  • [42] Pooled Analysis of Clinical Outcomes with Neoadjuvant Cisplatin and Gemcitabine Chemotherapy for Muscle Invasive Bladder Cancer
    Yuh, Bertram E.
    Ruel, Nora
    Wilson, Timothy G.
    Vogelzang, Nicholas
    Pal, Sumanta K.
    JOURNAL OF UROLOGY, 2013, 189 (05): : 1682 - 1686
  • [43] A real-time RT-PCR assay for quantitation of survivin gene expression in bladder cancer.
    Li, Z
    Kenney, DM
    Lutz, JM
    Kary, MR
    Sardesai, NY
    O'Shannessy, DJ
    CLINICAL CHEMISTRY, 2003, 49 (06) : A104 - A104
  • [44] Radiochemotherapy for invasive bladder cancer. An update
    Tselis, N.
    Prott, F. J.
    Ott, O.
    Weiss, C.
    Roedel, C.
    UROLOGE, 2018, 57 (06): : 679 - 685
  • [45] RTT training: bridging the gap between cervical cancer online IGRT and online proactive adaptive-RT
    Alexander, Sophie E.
    White, Ingrid
    Wang, Lei
    Patel, Roshni
    Lavender, Frances
    Blasiak-Wal, Irena
    Dunlop, Alex
    McNair, Helen A.
    Lalondrelle, Susan
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S5818 - S5821
  • [46] Realizing the potential of targeted therapy in non-muscle invasive bladder cancer.
    Black, Peter C.
    CLINICAL CANCER RESEARCH, 2020, 26 (15) : 22 - 22
  • [47] Neoadjuvant chemotherapy followed by concomitant chemoradiation with gemcitabine in muscle invasive bladder cancer.
    Mateen, Abdul
    Adil, Allah Rakha
    Ml, Quratul Ain Hash
    Duraishi, Arif Moin
    Abdullah, Famya
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [48] Effective and less toxic trimodality approach in muscle invasive urinary bladder cancer.
    Abdel-Wahab, Reham
    Eltaher, Ahmed M.
    Essa, Hoda H.
    Eid, Samir-Shehata M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [49] Delineation variability for rectal boost RT: the role of RTTs in CBCT-guided online-adaptive RT
    Pierrard, Julien
    Dechambre, David
    Vaandering, Aude
    Massih, Christel Abdel
    Cvilic, Sophie
    Roma, Ana Da Silva Chambel
    Henderickx, Pascale
    Heylen, Sofie
    Longton, Eleonore
    Mony, Romain
    Tenabene, Mohamed Amine
    Tison, Thais
    Vandermeulen, Ad
    Veken, Loic Vander
    Etume, Aniko Wale
    Yeo, Anne-Emmanuella
    Van Ooteghem, Genevieve
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S5967 - S5971
  • [50] A simple immunohistochemical algorithm to evaluate molecular subtypes and clinical associations in non-muscle invasive bladder cancer.
    Sjodahl, Gottfrid
    Berman, David M.
    Jackson, Chelsea L.
    Chen, Lina
    Ren, Kevin Y. M.
    Visram, Kash
    Siemens, Robert
    CLINICAL CANCER RESEARCH, 2020, 26 (15) : 51 - 52
12345